VNDAVanda Pharmaceuticals Inc.

5.280USD-5.21%Mkt Cap: 319.24M $P/E:

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for…

Key Statistics

Company
Market Cap319.24M $
Enterprise Value178.09M $
Revenue (TTM)215.72M $
Gross Profit203.06M $
Net Income (TTM)-220.47M $
Revenue/Share3.627 USD
Last Price5.280 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees533
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)26.90
PEG2.23
EV/EBITDA-1.01
EV/Revenue0.83
P/S1.51
P/B1.15
EPS (TTM)-4.47
EPS (Forward)0.20
52W Range
4.27018% of range9.940
52W High9.940 USD
52W Low4.270 USD
Profitability
Gross Margin93.96%
Oper. Margin-126.28%
EBITDA Margin-82.07%
Profit Margin-102.02%
ROE-67.38%
ROA-45.09%
Growth
Revenue Growth-3.90%
Earnings Growth
Cash Flow & Leverage
Operating CF-109.44M $
CapEx (TTM)998.00K $
FCF Margin-40.20%
FCF Yield-27.16%
Net Debt-147.20M $
Net Debt/EBITDA0.83
Balance Sheet
Debt/Equity0.04
Current Ratio1.61
Quick Ratio1.40
Book Value/Sh4.669 USD
Cash/Share2.812 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.19 USD
Upside (mean)+130.8%
Target Range5.750 USD20.00 USD
$5.750+130.8% to mean$20.00
# Analysts4
Ownership
Shares Out.60.46M
Float51.04M
Insiders6.61%
Institutions83.47%
Short Interest
Short Ratio9.0d
Short % Float12.88%
Short % Out.12.28%
Shares Short7.42M
Short (prev mo.)7.34M
Technical
SMA 505.624 (-6.1%)
SMA 2006.522 (-19.0%)
Beta0.64
S&P 52W Chg18.16%
Avg Vol (30d)949.70K
Avg Vol (10d)1.09M
Technical Indicators
RSI (14)48.2
MACD-0.1038
MACD Signal-0.1702
MACD Hist.+0.0664
BB Upper5.469 USD
BB Middle5.176 USD
BB Lower4.883 USD
BB Width11.32%
ATR (14)0.2735 USD
Vol Ratio (20d)0.65x